Table 1 Demographics and clinical characteristics of Patients with NAFLD and Controlsa
Characteristics | NAFLD patients (n = 182) | Controls (n = 195) | p Value |
|---|---|---|---|
Age, y | 46.09 ± 11.59 | 40.64 ± 11.53 | 0.000 |
Gender, Female/Male | 97/85 | 107/88 | 0.759 |
Height, cm | 167.17 ± 10.55 | 166.09 ± 6.46 | 0.237 |
Weight, kg | 74.28 ± 11.44 | 63.38 ± 11.10 | 0.000 |
Waist circumference, cm | 92.29 ± 9.29 | 82.46 ± 8.85 | 0.000 |
Hip circumference, cm | 103.11 ± 8.21 | 96.87 ± 8.80 | 0.000 |
ALT, U/L | 25.63 ± 14.41 | 19.71 ± 10.49 | 0.000 |
AST, U/L | 21.90 ± 11.23 | 19.64 ± 6.46 | 0.018 |
GGT, U/L | 22.19 ± 9.62 | 14.88 ± 5.69 | 0.000 |
TBIL, umol/L | 13.95 ± 6.40 | 13.36 ± 5.30 | 0.329 |
AKP, U/L | 68.18 ± 18.35 | 59.79 ± 13.81 | 0.000 |
GLU, mmol/L | 5.57 ± 1.79 | 4.96 ± 1.20 | 0.000 |
UA, umol/L | 364.42 ± 187.65 | 301.10 ± 76.82 | 0.000 |
TG, mmol/L | 1.98 ± 1.78 | 1.27 ± 1.58 | 0.000 |
TC, mmol/L | 4.92 ± 0.95 | 4.64 ± 0.93 | 0.004 |
HDL, mmol/L | 1.29 ± 0.46 | 1.48 ± 0.33 | 0.000 |
LDL, mmol/L | 3.30 ± 0.93 | 2.94 ± 0.80 | 0.000 |